Intraplantar PGE 2 causes nociceptive behaviour and mechanical allodynia: The role of prostanoid e receptors and protein kinases

British Journal of Pharmacology

Volumn 150, Issue 6, 2007, Pages 727-737

  Kassuya, C A L ^a   Ferreira, J ^b   Claudino, R F ^a   Calixto, J B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Mice; Mitogen activated protein kinases; Nociception; Prostaglandin E 2; Prostanoid E receptors; Protein kinases

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTANOID RECEPTOR; PROTEIN KINASE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C INHIBITOR; RECEPTOR BLOCKING AGENT; RECEPTOR SUBUNIT; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; 17 PHENYLTRINORPROSTAGLANDIN E2; 17-PHENYLTRINORPROSTAGLANDIN E2; ACRYLAMIDE DERIVATIVE; CARRAGEENAN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DRUG DERIVATIVE; L 826266; L-826266; NAPHTHALENE DERIVATIVE; PROSTAGLANDIN E; PROSTAGLANDIN E RECEPTOR; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; EX VIVO STUDY; IN VIVO STUDY; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; WESTERN BLOTTING; ANIMAL; CLASSIFICATION; DRUG ANTAGONISM; DRUG EFFECT; IN VITRO STUDY; MECHANICAL STRESS; METABOLISM; NOCICEPTIVE RECEPTOR; PAIN ASSESSMENT; PHYSIOLOGY;

ACRYLAMIDES; ANIMALS; CARRAGEENAN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DINOPROSTONE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MALE; MICE; NAPHTHALENES; NOCICEPTORS; PAIN MEASUREMENT; PROSTAGLANDINS E, SYNTHETIC; PROTEIN KINASE C; PROTEIN KINASES; RECEPTORS, PROSTAGLANDIN E; STRESS, MECHANICAL;

EID: 33947324676     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707149     Document Type: Article

References (50)

1. Abramovitz M, Adam M, Boie Y, Carriere M, Denis D, Godbout C et al. (2000). The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogs. Biochim Biophys Acta 1483: 285-293.
2. Aley KO, Levine JD (1999). Role of protein kinase A in the maintenance of inflammatory pain. J Neurosci 19: 2181-2186.
3. Aley KO, Martin A, McMahon T, Mok J, Levine JD, Messing RO (2001). Nociceptor sensitization by extracellular signal-regulated kinases. J Neurosci 21: 6933-6939.
4. André E, Ferreira J, Malheiros A, Yunes RA, Calixto JB (2004). Evidence for the involvement of vanilloid receptor in the antinociception produced by the dialdeydes unsaturated sesquiterpenes polygodial and drimanial in rats. Neuropharmacology 46: 590-597.
5. Burkey TH, Regan JW (1995). Activation of mitogen-activated protein kinase by the human prostaglandin EP3A receptor. Biochem Biophys Res Commun 211: 152-158.
6. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994). Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53: 55-63.
7. Claudino RF, Kassuya CAL, Ferreira J, Calixto JB (2006). Pharmacological and molecular characterization of the mechanisms involved in the prostaglandin E2 (PGE2)-induced edematogenic responses in mice. J Pharmacol Exp Ther 318: 611-618.
8. Cunha FQ, Teixeira MM, Ferreira SH (1999). Pharmacological modulation of secondary mediator systems-cyclic AMP and cyclic GMP - on inflammatory hyperalgesia. Br J Pharmacol 127: 671-678.
9. Ferreira J, Da Silva GL, Calixto JB (2004). Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice. Br J Pharmacol 141: 787-794.
10. Ferreira J, Triches KM, Medeiros R, Calixto JB (2005). Mechanisms involved in the nociception produced by peripheral protein kinase Cactivation in mice. Pain 117: 171-181.
11. Ferreira SH (1972). Prostaglandin, aspirin-like drugs and analgesia. Nat New Biol 240: 200-203.
12. Ferreira SH, Nakamura M (1979). I - Prostaglandin hyperalgesia, a cAMP/Ca2+ dependent process. Prostaglandins 18: 179-190.
13. Fiebich BL, Schleicher S, Spleiss O, Czygan M, Hull M (2001). Mechanisms of prostaglandin E2-induced interleukin-6 release in astrocytes: possible involvement of EP4-like receptors, p38 mitogenactivated protein kinase and protein kinase C. J Neurochem 79: 950-958.
14. Gold MS, Levine JD, Correa AM (1998). Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci 18: 10345-10355.
15. Hata AN, Breyer RM (2004). Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther 103: 147-166.
16. Hatae N, Sugimoto Y, Ichikawa A (2002). Prostaglandin receptors: advances in the study of EP3 receptor signaling. J Biochem 131: 781-784.
17. Herencia F, Ubeda A, Ferrandiz ML, Terencio MC, Alcaraz MJ, Garcia-Carrascosa M et al. (1998). Anti-inflammatory activity in mice of extracts from Mediterranean marine invertebrates. Life Sci 62: PL115-PL120.
18. Hong Y, Abbott FV (1994). Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience 63: 827-836.
19. Inoue M, Kawashima T, Allen RG, Ueda H (2003). Nocistatin and prepro-nociceptin/orphanin FQ 160-187 cause nociception through activation of Gi/o in capsaicin-sensitive and of Gs in capsaicin-insensitive nociceptors, respectively. J Pharmacol Exp Ther 306: 141-146.
20. Khasar SG, Gold MS, Levine JD (1998). A tetrodotoxin-resistant sodium current mediates inflammatory pain in the rat. Neurosci Lett 256: 17-20.
21. Khasar SG, Lin YH, Martin A, Dadgar J, McMahon T, Wang D et al. (1999). A novel nociceptor signaling pathway revealed in protein kinase C epsilon mutant mice. Neuron 24: 253-260.
22. Khasar SG, Ouseph AK, Chou B, Ho T, Green PG, Levine JD (1995). Is there more than one prostaglandin E receptor subtype mediating hyperalgesia in the rat hindpaw? Neuroscience 64: 1161-1165.
23. Kiriyama M, Ushikubi F, Kobayashi T, Hirata M, Sugimoto Y, Narumiya S (1997). Ligand binding specificities of the eight types and subtypes of the mouse prostanoid E receptors expressed in Chinese hamster ovary cells. Br J Pharmacol 22: 217-224.
24. Kobayashi T, Narumiya S (2002). Prostanoids in health and disease; lessons from receptor-knockout mice. Adv Exp Med Biol 507: 593-597.
25. Kopp UC, Cicha MZ, Nakamura K, Nusing RM, Smith LA, Hokfelt T (2004). Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves. Am J Physiol Renal Physiol 287: 1269-1282.
26. Kuhn DC,Willis AL (1973). Prostaglandin E2, inflammation and pain threshold in rat paws. Br J Pharmacol 49: 183-184.
27. Kumazawa T, Mizumura K, Koda H (1993). Involvement of EP3 subtype of prostaglandin E receptors in PGE2-induced enhancement of the bradykinin response of nociceptors. Brain Res 632: 321-324.
28. Kumazawa T, Mizumura K, Koda H, Fukusako H (1996). EP receptor subtypes implicated in the PGE2-induced sensitization of polymodal receptors in response to bradykinin and heat. J Neurophysiol 75: 2361-2368.
29. Machwate M, Harada S, Leu CT, Seedor G, Labelle M, Gallant M et al. (2001). Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2). Mol Pharmacol 60: 36-41.
30. Mak TW, Penninger JM, Ohashi PS (2001). Knockout mice: a paradigm shift in modern immunology. Nat Rev Immunol 1: 11-19.
31. Malmberg AB, Brandon EP, Idzerda RL, Liu H, Mcknight GS, Basbaum AI (1997). Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the type I regulatory subunit of cAMP-dependent protein kinase. J Neurosci 17: 7462-7470.
32. Mendez M, Lapointe MC (2005). PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation. Am J Physiol Heart Circ Physiol 288: H2111-H2117.
33. Mense S (1981). Sensitization of group IV muscle receptors to bradykinin by 5-hydroxytryptamine and prostaglandin E2. Brain Res 225: 95-105.
34. Mizumura K, Minagawa M, Tsujii Y, Kumazawa T (1993). Prostaglandin E2-induced sensitization of the heat response of canine visceral polymodal receptors in vitro. Neurosci Lett 161: 117-119.
35. Mizumura K, Sato J, Kumazawa T (1987). Effects of prostaglandins and other putative chemical intermediaries on the activity of canine testicular polymodal receptors studied in vitro. Pflueg Arch 408: 565-572.
36. Noda K, Ueda Y, Suzuki K, Yoda K (1997). Excitatory effects of algesic compounds on neuronal processes in murine dorsal root ganglion cell culture. Brain Res 751: 348-351.
37. Oida H, Namba T, Sugimoto Y, Ushikubi F, Ohishi H, Ichikawa A et al. (1995). In situ hybridization studies of prostacyclin receptor mRNA expression in various mouse organs. Br J Pharmacol 116: 2828-2837.
38. Reinold H, Ahmadi S, Depner UB, Layh B, Heindl C, Hamza M et al. (2005). Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype. J Clin Invest 115: 673-679.
39. Samad TA, Sapirstein A, Woolf CJ (2002). Prostanoids and pain: unraveling mechanism therapeutics targets. Trends Mol Med 8: 390-396.
40. Schaible HG, Schimdt RF (1988). Excitation and sensitization of fine articular afferents from cat's knee joint by prostaglandin E2. J Physiol 403: 91-104.
41. Schlemper V, Medeiros R, Ferreira J, Campos MM, Calixto JB (2005). Mechanisms underlying the relaxation response induced by bradykinin in the epithelium-intact guinea-pig trachea in vitro. Br J Pharmacol 145: 740-750.
42. Smith JA, Amagasu SM, Eglen RM, Hunter JC, Bley KR (1998). Characterization of prostanoid receptor-evoked responses in rat sensory neurones. Br J Pharmacol 124: 513-523.
43. 2-induced cAMP production and sensitization of sensory neurons. J Biol Chem 276: 16083-16091.
44. Sugimoto Y, Shigemoto R, Namba T, Negishi M, Mizuno N, Narumiya S et al. (1994). Distribution of the messenger RNA for the prostaglandin E receptor subtype EP3 in the mouse nervous system. Neuroscience 62: 919-928.
45. Taiwo YO, Levine JD (1991). Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience 44: 131-135.
46. Tasken K, Aandahl EM (2004). Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev 84: 137-167.
47. Vellani V, Zachrisson O, McNaughton PA (2004). Functional bradykinin B1 receptors are expressed in nociceptive neurones and are upregulated by the neurotrophin GDNF. J Physiol 560: 391-401.
48. Woolf CJ, Mannion RJ (1999). Neuropathic pain: aetiology, symptoms, mechanism and management. Lancet 353: 1959-1964.
49. Zhuang ZY, Xu H, Clapham DE, Ji RR (2004). Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization. J Neurosci 24: 8300-8309.
50. Zimmermann M (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.